von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance by Louise M Binderup, Marie, Smerdel, Maja, Borgwadt, Line, Beck Nielsen, Signe Sparre, Madsen, Mia Gebauer, Møller, Hans Ulrik, Kiilgaard, Jens Folke, Friis-Hansen, Lennart, Harbud, Vibeke, Cortnum, Søren, Owen, Hanne, Gimsing, Steen, Friis Juhl, Henning Anker, Munthe, Sune, Geilswijk, Marianne, Rasmussen, Åse Krogh, Møldrup, Ulla, Graumann, Ole, Donskov, Frede, Grønbæk, Henning, Stausbøl-Grøn, Brian, Schaffalitzky de Muckadell, Ove, Knigge, Ulrich, Dam, Gitte, Wadt, Karin AW, Bøgeskov, Lars, Bagi, Per, Lund, Lars, Stochholm, Kirstine, Ousager, Lilian Bomme, Sunde, Lone

Get full text

Noise-Induced Hearing Loss: Prevention is Possible by Gimsing, Steen, Nielsen, Marianne G.

Get full text

von Hippel-Lindau disease: Deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening by Binderup, Marie Louise Mølgaard, Gimsing, Steen, Kosteljanetz, Michael, Thomsen, Carsten, Bisgaard, Marie Luise

Get full text

Inversion of the stapedial reflex in ossicular chain lesions by Gimsing, Steen

Get full text

Otoscopy compared with tympanometry: A study evaluating the accuracy of otoscopy in 1702 unselected ears by Gimsing, Steen, Bergholtz, Lars M.

Get full text

Otoscopy compared with tympanometry by Gimsing, Steen, Bergholtz, Lars M.

Get full text

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma by Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A. Kate, Guckert, Mary E., de Boer, Carla, Khokhar, Nushmia Z., Yeh, Howard, Clemens, Pamela L., Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.

Get full text

Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study by Plesner, Torben, Lokhorst, Henk, Gimsing, Peter, Nahi, Hareth, Lisby, Steen, Richardson, Paul G.

Get full text

Drug Response Prediction in High Risk Multiple Myeloma by Vangsted, Annette Juul, Helm-Petersen, Sissel, Cowland, Jack, Jensen, Peter Buhl, Gimsing, Peter, Knudsen, Steen

Get full text

A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma – Preliminary Safety Data by Gimsing, Peter, Plesner, Torben, Nahi, Hareth, Lokhorst, Henk, Valentin, Marie-Louise, Lisby, Steen, Richardson, Paul G.

Get full text

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Updated Results of a Phase 1/2 Study (GEN503) by Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A Kate, Guckert, Mary E, Yeh, Howard, Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.

Get full text

Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma by Plesner, Torben, Arkenau, Hendrik-Tobias, Lokhorst, Henk M., Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Ahmadi, Tahamtan, Yeh, Howard, Guckert, Mary E, Feng, Huaibao, Brun, Nikolai Constantin, Lisby, Steen, Basse, Linda, Palumbo, Antonio, Richardson, Paul G.

Get full text